tiagabine vs triazolam
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of tiagabine and triazolam. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Ethanol or Triazolam: No significant differences were observed in the pharmacokinetics of triazolam (0.125 mg) and tiagabine (10 mg) when given together as a single dose. Tiagabine has shown no clinically important potentiation of the pharmacodynamic effects of triazolam or alcohol. Because of the possible additive effects of drugs that may depress the nervous system, ethanol or triazolam should be used cautiously in combination with tiagabine.
Tiagabine is a medicine used with other medicines to treat partial seizures. It helps to control seizures by affecting certain chemicals in the brain.
Triazolam (Halcion) is a medication used for the short-term treatment of insomnia. It belongs to a class of drugs called benzodiazepines, which help you fall asleep.
Tiagabine is used to treat partial seizures in adults and children 12 years and older. It is used along with other seizure medicines. Partial seizures affect only one part of the brain.
Triazolam is used to treat insomnia in adults. Insomnia is when you have trouble falling asleep or staying asleep. This medicine is only for short-term use, usually for 7 to 10 days.
Tiagabine works by increasing the amount of a chemical called GABA in the brain. GABA helps to calm the brain and reduce seizures. Tiagabine blocks the reuptake of GABA, which means more GABA is available in the brain.
Triazolam works by slowing down activity in the brain. This helps you to relax and fall asleep. It affects certain chemicals in your brain called neurotransmitters.
- • Dizziness
- • Lack of energy
- • Sleepiness
- • Nausea
- • Nervousness or irritability
- • Drowsiness
- • Headache
- • Dizziness
- • Nervousness
- • Light-headedness
- Encephalopathy 16
- Myoclonus 14
- Dizziness 6
- Feeling Abnormal 5
- Seizure 5
- Drug Abuse 519
- Sopor 402
- Nausea 352
- Overdose 350
- Fall 315
This medicine may cause serious side effects. Tell your doctor right away if you have any changes in mood or behavior, or any suicidal thoughts.
Taking triazolam with opioid pain medicines can cause very serious problems, including slowed or stopped breathing, coma, and death. Because of these risks, doctors will only prescribe opioid pain medicines with triazolam when other treatment options are not sufficient. Do not misuse this medicine. Misuse can lead to addiction, overdose, or death. Stopping triazolam suddenly can cause dangerous withdrawal symptoms. Talk to your doctor before stopping this medicine.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if tiagabine will harm your unborn baby. Talk to your doctor about the risks and benefits of taking tiagabine during pregnancy.
Taking triazolam late in pregnancy may cause sedation or withdrawal symptoms in the newborn. If you are pregnant or plan to become pregnant, talk to your doctor about the risks and benefits of taking triazolam. A registry exists to track outcomes in women who take psychiatric medications, including triazolam, during pregnancy.
Also Compare, Nearby Drugs
Compare triazolam with
How to Read This tiagabine vs triazolam Comparison
tiagabine is classified in the Anticonvulsant (GABA Reuptake Inhibitor) drug class, while triazolam sits within the Benzodiazepine (Hypnotic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, tiagabine has 46 submissions while triazolam has 1,938. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to both of these medicines can slow down the central nervous system, which may cause extra sleepiness or dizziness when they are used at the same time.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for tiagabine or triazolam.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.